JoanneKurtzbergMD

Pediatric Hematology & Oncology • Durham, NC

Professor of Pediatrics, Duke University

Join to view full profile

Dr. Kurtzberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kurtzberg's full profile

Already have an account?

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-620-4467

Education & Training

Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1980 - 1983
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1979 - 1980
SUNY Upstate Medical UniversityResidency, Pediatrics, 1977 - 1979
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Pediatrics, 1976 - 1977
New York Medical CollegeClass of 1976

Certifications & Licensure

FL State Medical License 2021 - 2026
NC State Medical License 1983 - 2025
NJ State Medical License 2021 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Fellow (FAAP) American Academy of Pediatrics
Join now to see all

Clinical Trials

Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
Completed
Not Applicable
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Start of enrollment: 1999 Jan 01
Completed
Phase 2
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Completed
Phase 3
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
Terminated
Phase 2, Phase 3
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
Completed
Phase 2
Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients Start of enrollment: 2005 Nov 18
Completed
Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis Start of enrollment: 2007 Jul 01
Withdrawn
Phase 1, Phase 2
Adult Double Cord Blood Transplant Study Start of enrollment: 2007 Aug 01
Completed
Phase 2
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy Start of enrollment: 2008 Jan 01
Completed
Phase 1
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases Start of enrollment: 2008 Mar 01
Terminated
Phase 3
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies Start of enrollment: 2007 Aug 01
Completed
Phase 1, Phase 2
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells Start of enrollment: 2005 Oct 01
Completed
Phase 1
Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases Start of enrollment: 2009 Oct 01
Withdrawn
Phase 1
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Start of enrollment: 2010 Jun 01
Completed
Phase 2
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies Start of enrollment: 2010 Nov 01
Completed
Phase 1, Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Roles: Contact, Principal Investigator
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders Start of enrollment: 2011 Apr 01
Terminated
Phase 1, Phase 2
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome Start of enrollment: 2011 Sep 01
Terminated
Phase 1
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation Start of enrollment: 2012 Mar 01
Withdrawn
Phase 2
Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies Start of enrollment: 2012 Sep 01
Completed
Phase 1, Phase 2
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Available
Single Patient Expanded Access Protocol: Metabolic Boost
No longer available
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
No longer available
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2014 Jun 01
Completed
Phase 1
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells Start of enrollment: 2014 Sep 01
Recruiting
Phase 1
Cord Blood Infusion for Children With Autism Spectrum Disorder Start of enrollment: 2016 Sep 01
Completed
Phase 2
Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke Start of enrollment: 2017 Mar 14
Completed
Phase 2
hCT-MSCs for Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2017 Jun 06
Completed
Phase 1
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Available
A Study of UCB and MSCs in Children With CP: ACCeNT-CP Start of enrollment: 2018 Apr 10
Completed
Phase 1, Phase 2
Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE Start of enrollment: 2018 Dec 27
Completed
Phase 1
hCT-MSC in Children With Autism Spectrum Disorder Start of enrollment: 2020 Oct 12
Completed
Phase 2
Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder Start of enrollment: 2021 Feb 24
Completed
Phase 1
hCT-MSCs for COVID19 ARDS Start of enrollment: 2020 Jun 18
Terminated
Phase 1, Phase 2
hCT-MSC Infusion in Adults With Autism Spectrum Disorder Start of enrollment: 2022 Jan 24
Active, not recruiting
Phase 1
Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome Start of enrollment: 2021 Mar 12
Withdrawn
Phase 1
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Start of enrollment: 2022 Apr 19
Recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Newborn Screening for Hurler Syndrome Facilitates Early Transplant and Good Outcomes.
Andrea Bauchat, Andre Stokhuyzen, Timothy A Driscoll, Paul L Martin, Joanne Kurtzberg
Pediatric Neurology. 2024-11-12
In utero human cytomegalovirus infection expands NK-like FcγRIII+ CD8+ T cells that mediate Fc antibody functions.
Eleanor C Semmes, Danielle R Nettere, Ashley N Nelson, Jillian H Hurst, Derek W Cain
The Journal of Clinical Investigation. 2024-11-12
Safety and feasibility of umbilical cord blood transplantation in children with neuronal ceroid lipofuscinosis: a retrospective study.
Andrea Bauchat, Veronika Polishchuk, Vanessa A Fabrizio, Jennifer E Brondon, Kristin M Page
Stem Cells Translational Medicine. 2024-10-29

Abstracts/Posters

Automated Thawing Increases Recovery of Colony‐Forming Units from Banked Cord Blood Unit Grafts
Joanne Kurtzberg, MD, Transfusion, Orlando, FL, 12/7/2019

Press Mentions

$FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids$
FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in KidsDecember 19th, 2024
FDA OKs First Mesenchymal Stromal Cell Therapy for GVHDDecember 19th, 2024
More Options for People with Blood CancersMay 10th, 2023
Join now to see all